Monocyte and macrophage subtypes as paired cell biomarkers for coronary artery disease

被引:21
|
作者
Arnold, Kathryn A. [1 ]
Blair, John E. [2 ]
Paul, Jonathan D. [2 ]
Shah, Atman P. [2 ]
Nathan, Sandeep [2 ]
Alenghat, Francis J. [2 ]
机构
[1] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Sect Cardiol, 5841 S Maryland Ave, Chicago, IL 60637 USA
关键词
cell-based biomarkers; coronary artery disease; macrophage; monocyte; PLAQUE VULNERABILITY; POLARIZATION; ATHEROSCLEROSIS; SUBSETS; EXPRESSION; RECEPTOR; ALPHA;
D O I
10.1113/EP087827
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
New Findings What is the central question of this study?Are circulating monocyte markers correlated with their derived macrophage polarization patterns and coronary artery disease severity? What is the main finding and its importance?There was an inverse relationship between circulating CD16(+) monocytes (high) and M2 macrophages (low) that marked coronary disease severity, and the differences in polarization of macrophages were seen despite a week of cell culture ex vivo. This study highlights the importance, and potential prognostic implications, of circulating monocyte and descendant macrophage phenotypes in coronary artery disease. Monocytes and macrophages are central to atherosclerosis, but how they combine to mark progression of human coronary artery disease (CAD) is unclear. We tested whether patients' monocyte subtypes paired with their derived macrophage profiles were correlated with extent of CAD. Peripheral blood was collected from 40 patients undergoing cardiac catheterization, and patients were categorized as having no significant CAD, single vessel disease or multivessel disease according to the number of affected coronary arteries. Mononuclear cells were measured for the monocyte markers CD14 and CD16 by flow cytometry, and separate monocytes were cultured into macrophages over 7 days and measured for the polarization markers CD86 and CD206. At baseline, patients with a greater CAD burden were older, with higher rates of statin, beta-blocker and antiplatelet drug use, whereas other characteristics were similar across the spectrum of coronary disease. CD16(+) (both intermediate and non-classical) monocytes were elevated in patients with single vessel and multivessel disease compared with those without significant CAD (P < 0.05), whereas regulatory M2 macrophages (CD206(+)) were decreased in patients with single vessel and multivessel disease (P < 0.001). An inverse relationship between paired CD16(+) monocytes and M2 macrophages marked CAD severity. On multivariable linear regression, CAD severity was associated, along with age and traditional cardiovascular risk factors, with CD16(+) monocytes (directly) and M2 macrophages (inversely). Circulating monocytes may influence downstream polarization of lesional macrophages, and these measures of monocyte and macrophage subtypes hold potential as biomarkers in CAD.
引用
收藏
页码:1343 / 1352
页数:10
相关论文
共 50 条
  • [1] Epigenetic upregulation of CLEC5A contributes to monocyte/macrophage dysfunction in coronary artery disease
    Qi, Daoxi
    Wang, Fan
    Zhang, Xiaokang
    Li, Boyu
    Zhou, Wenjie
    Sheng, Shuyang
    Zhu, Ruiyang
    Cao, Liang
    Zhao, Chang
    Deng, Xinyu
    Ouyang, Tanglin
    Zheng, Fang
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 308
  • [2] Predictive role of monocyte count for significant coronary artery disease identification in patients with stable coronary artery disease
    Urbanowicz, Tomasz
    Olasinska-Wisniewska, Anna
    Michalak, Michal
    Komosa, Anna
    Filipiak, Krzysztof J.
    Uruski, Pawel
    Radziemski, Artur
    Tykarski, Andrzej
    Jemielity, Marek
    CARDIOLOGY JOURNAL, 2024, 31 (05)
  • [3] Association of lymphocyte to monocyte ratio with severity of coronary artery disease
    Gong, Shu
    Gao, Ximei
    Xu, Fubiao
    Shang, Zhi
    Li, Shuai
    Chen, Wenqiang
    Yang, Jianmin
    Li, Jifu
    MEDICINE, 2018, 97 (43)
  • [4] Monocyte gene expression and coronary artery disease
    Maiwald, Stephanie
    Zwetsloot, Peter-Paul
    Sivapalaratnam, Suthesh
    Dallinga-Thie, Geesje M.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2013, 16 (04) : 411 - 417
  • [5] A Novel Macrophage Subpopulation Conveys Increased Genetic Risk of Coronary Artery Disease
    Jiang, Jiahao
    Hiron, Thomas K.
    Agbaedeng, Thomas A.
    Malhotra, Yashaswat
    Drydale, Edward
    Bancroft, James
    Ng, Esther
    Reschen, Michael E.
    Davison, Lucy J.
    O'Callaghan, Chris A.
    CIRCULATION RESEARCH, 2024, 135 (01) : 6 - 25
  • [6] Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis
    Shantsila, Eduard
    Tapp, Luke D.
    Wrigley, Benjamin J.
    Pamukcu, Burak
    Apostolakis, Stavros
    Montoro-Garcia, Silvia
    Lip, Gregory Y. H.
    ATHEROSCLEROSIS, 2014, 234 (01) : 4 - 10
  • [7] MicroRNAs as Potential Biomarkers in Coronary Artery Disease
    Bergami, Maria
    Fabin, Natalia
    Cenko, Edina
    Bugiardini, Raffaele
    Manfrini, Olivia
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2023, 23 (06) : 454 - 469
  • [8] Clinical and Genomic Prediction of Coronary Artery Disease Subtypes
    Liou, Lathan
    Garcia-Gonzalez, Judit
    Wu, Hei Man
    Wang, Zhe
    Hoggart, Clive J.
    Kontorovich, Amy R.
    Kovacic, Jason C.
    O'Reilly, Paul F.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2025, 45 (01) : 90 - 103
  • [9] Identification of potential M2 macrophage-associated diagnostic biomarkers in coronary artery disease
    Li, Kunlin
    Kong, Ruize
    Ma, Lijing
    Cao, Yu
    Li, Wei
    Chen, Rui
    Gong, Kunmei
    Jiang, Lihong
    BIOSCIENCE REPORTS, 2022, 42 (12)
  • [10] NFAT activating protein with ITAM motif 1 (NFAM1) is upregulated on circulating monocytes in coronary artery disease and potentially correlated with monocyte chemotaxis
    Long, Jie
    Chen, Jiemei
    Wang, Qingchun
    Gao, Feng
    Lian, Ming
    Zhang, Peng
    Yang, Yuejin
    Zhu, Haibo
    ATHEROSCLEROSIS, 2020, 307 : 39 - 51